Global Brain Disease Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 121 pages | ID: G24EB85F2D8GEN
GlobalInfoResearch

Abstracts

Brain diseases a part of central nervous system diseases, is a condition where the brain structure or functions alter. The brain diseases include conditions or disabilities that affect the brain. Mostly brain disorders occur due to traumatic injury, genetic or other diseases, while a small number of brain diseases occur due to environmental factors. The major concerned brain disease are caused due to brain deterioration which may lead to neurodegenerative diseases such as Alzheimer?s, Huntington?s disease, and others. The mental disorders or mental illness occurrence is also related to the brain diseases, which include depression, anxiety, bipolar disorders, and others. The etiology of brain disease is not specific. It can occur to anyone and the risk factors of brain diseases differ in accordance to the different types of brain diseases. The sign and symptoms also differ for every brain diseases. Some of the most common symptoms include headache, memory loss, tremors, increased reflexes, slurred speech, paralysis, and inability to concentrate among others. Moreover, the treatment of brain diseases range from surgery to rehabilitation to medications; depending upon the brain disease the patient is affected by. The brain diseases are progressive which may affect the daily life of patients and hence should be immediately treated upon their diagnosis or detection.

SCOPE OF THE REPORT:

This report studies the Brain Disease market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Brain Disease market by product type and applications/end industries.
The incidence and prevalence of brain diseases and disorders increase with age. The growing baby booming population is the major factor driving the brain disease market, globally. Rising prevalence of brain diseases is expected to boost the growth of the market. Due lack of effective treatment for some brain diseases such as brain cancer, they are a huge demand for medicinal treatment. Because of this reason, key market players are intensively focusing on R&D to develop a safe and effective treatment for brain diseases. All these factors act as driver for burgeoning growth of the brain disease market. However, adverse effects associated with the medications of brain diseases is anticipated to hinder the market growth.
The global Brain Disease market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Brain Disease.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Pfizer
• Eli Lilly
• F. Hoffmann La Roche
• GE Healthcare
• Janssen Pharmaceuticals
• Abbvie
• AC Immune
• Allergan
• Merck
• Novartis
• AstraZeneca

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Brain Cancer
• Alzheimer Disease
• Alcoholism
• Amnesia
• Epilepsy
• Meningitis
• Others

Market Segment by Applications, can be divided into

• Hospitals Pharmacy
• Online Pharmacy
• Pharmacy

Contents

1 BRAIN DISEASE MARKET OVERVIEW

1.1 Product Overview and Scope of Brain Disease
1.2 Classification of Brain Disease by Types
  1.2.1 Global Brain Disease Revenue Comparison by Types (2017-2023)
  1.2.2 Global Brain Disease Revenue Market Share by Types in 2017
  1.2.3 Brain Cancer
  1.2.4 Alzheimer Disease
  1.2.5 Alcoholism
  1.2.6 Amnesia
  1.2.7 Epilepsy
  1.2.8 Meningitis
  1.2.9 Others
1.3 Global Brain Disease Market by Application
  1.3.1 Global Brain Disease Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals Pharmacy
  1.3.3 Online Pharmacy
  1.3.4 Pharmacy
1.4 Global Brain Disease Market by Regions
  1.4.1 Global Brain Disease Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Brain Disease Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Brain Disease Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Brain Disease Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Brain Disease Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Brain Disease Status and Prospect (2013-2023)
1.5 Global Market Size of Brain Disease (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Pfizer
  2.1.1 Business Overview
  2.1.2 Brain Disease Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Pfizer Brain Disease Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eli Lilly
  2.2.1 Business Overview
  2.2.2 Brain Disease Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Eli Lilly Brain Disease Revenue, Gross Margin and Market Share (2016-2017)
2.3 F. Hoffmann La Roche
  2.3.1 Business Overview
  2.3.2 Brain Disease Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 F. Hoffmann La Roche Brain Disease Revenue, Gross Margin and Market Share (2016-2017)
2.4 GE Healthcare
  2.4.1 Business Overview
  2.4.2 Brain Disease Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 GE Healthcare Brain Disease Revenue, Gross Margin and Market Share (2016-2017)
2.5 Janssen Pharmaceuticals
  2.5.1 Business Overview
  2.5.2 Brain Disease Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Janssen Pharmaceuticals Brain Disease Revenue, Gross Margin and Market Share (2016-2017)
2.6 Abbvie
  2.6.1 Business Overview
  2.6.2 Brain Disease Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Abbvie Brain Disease Revenue, Gross Margin and Market Share (2016-2017)
2.7 AC Immune
  2.7.1 Business Overview
  2.7.2 Brain Disease Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 AC Immune Brain Disease Revenue, Gross Margin and Market Share (2016-2017)
2.8 Allergan
  2.8.1 Business Overview
  2.8.2 Brain Disease Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Allergan Brain Disease Revenue, Gross Margin and Market Share (2016-2017)
2.9 Merck
  2.9.1 Business Overview
  2.9.2 Brain Disease Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Merck Brain Disease Revenue, Gross Margin and Market Share (2016-2017)
2.10 Novartis
  2.10.1 Business Overview
  2.10.2 Brain Disease Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Novartis Brain Disease Revenue, Gross Margin and Market Share (2016-2017)
2.11 AstraZeneca
  2.11.1 Business Overview
  2.11.2 Brain Disease Type and Applications
    2.11.2.1 Product A
    2.11.2.2 Product B
  2.11.3 AstraZeneca Brain Disease Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL BRAIN DISEASE MARKET COMPETITION, BY PLAYERS

3.1 Global Brain Disease Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Brain Disease Players Market Share
  3.2.2 Top 10 Brain Disease Players Market Share
3.3 Market Competition Trend

4 GLOBAL BRAIN DISEASE MARKET SIZE BY REGIONS

4.1 Global Brain Disease Revenue and Market Share by Regions
4.2 North America Brain Disease Revenue and Growth Rate (2013-2018)
4.3 Europe Brain Disease Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Brain Disease Revenue and Growth Rate (2013-2018)
4.5 South America Brain Disease Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Brain Disease Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA BRAIN DISEASE REVENUE BY COUNTRIES

5.1 North America Brain Disease Revenue by Countries (2013-2018)
5.2 USA Brain Disease Revenue and Growth Rate (2013-2018)
5.3 Canada Brain Disease Revenue and Growth Rate (2013-2018)
5.4 Mexico Brain Disease Revenue and Growth Rate (2013-2018)

6 EUROPE BRAIN DISEASE REVENUE BY COUNTRIES

6.1 Europe Brain Disease Revenue by Countries (2013-2018)
6.2 Germany Brain Disease Revenue and Growth Rate (2013-2018)
6.3 UK Brain Disease Revenue and Growth Rate (2013-2018)
6.4 France Brain Disease Revenue and Growth Rate (2013-2018)
6.5 Russia Brain Disease Revenue and Growth Rate (2013-2018)
6.6 Italy Brain Disease Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC BRAIN DISEASE REVENUE BY COUNTRIES

7.1 Asia-Pacific Brain Disease Revenue by Countries (2013-2018)
7.2 China Brain Disease Revenue and Growth Rate (2013-2018)
7.3 Japan Brain Disease Revenue and Growth Rate (2013-2018)
7.4 Korea Brain Disease Revenue and Growth Rate (2013-2018)
7.5 India Brain Disease Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Brain Disease Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA BRAIN DISEASE REVENUE BY COUNTRIES

8.1 South America Brain Disease Revenue by Countries (2013-2018)
8.2 Brazil Brain Disease Revenue and Growth Rate (2013-2018)
8.3 Argentina Brain Disease Revenue and Growth Rate (2013-2018)
8.4 Colombia Brain Disease Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE BRAIN DISEASE BY COUNTRIES

9.1 Middle East and Africa Brain Disease Revenue by Countries (2013-2018)
9.2 Saudi Arabia Brain Disease Revenue and Growth Rate (2013-2018)
9.3 UAE Brain Disease Revenue and Growth Rate (2013-2018)
9.4 Egypt Brain Disease Revenue and Growth Rate (2013-2018)
9.5 Nigeria Brain Disease Revenue and Growth Rate (2013-2018)
9.6 South Africa Brain Disease Revenue and Growth Rate (2013-2018)

10 GLOBAL BRAIN DISEASE MARKET SEGMENT BY TYPE

10.1 Global Brain Disease Revenue and Market Share by Type (2013-2018)
10.2 Global Brain Disease Market Forecast by Type (2018-2023)
10.3 Brain Cancer Revenue Growth Rate (2013-2023)
10.4 Alzheimer Disease Revenue Growth Rate (2013-2023)
10.5 Alcoholism Revenue Growth Rate (2013-2023)
10.6 Amnesia Revenue Growth Rate (2013-2023)
10.7 Epilepsy Revenue Growth Rate (2013-2023)
10.8 Meningitis Revenue Growth Rate (2013-2023)
10.9 Others Revenue Growth Rate (2013-2023)

11 GLOBAL BRAIN DISEASE MARKET SEGMENT BY APPLICATION

11.1 Global Brain Disease Revenue Market Share by Application (2013-2018)
11.2 Brain Disease Market Forecast by Application (2018-2023)
11.3 Hospitals Pharmacy Revenue Growth (2013-2018)
11.4 Online Pharmacy Revenue Growth (2013-2018)
11.5 Pharmacy Revenue Growth (2013-2018)

12 GLOBAL BRAIN DISEASE MARKET SIZE FORECAST (2018-2023)

12.1 Global Brain Disease Market Size Forecast (2018-2023)
12.2 Global Brain Disease Market Forecast by Regions (2018-2023)
12.3 North America Brain Disease Revenue Market Forecast (2018-2023)
12.4 Europe Brain Disease Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Brain Disease Revenue Market Forecast (2018-2023)
12.6 South America Brain Disease Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Brain Disease Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Brain Disease Picture
Table Product Specifications of Brain Disease
Table Global Brain Disease and Revenue (Million USD) Market Split by Product Type
Figure Global Brain Disease Revenue Market Share by Types in 2017
Figure Brain Cancer Picture
Figure Alzheimer Disease Picture
Figure Alcoholism Picture
Figure Amnesia Picture
Figure Epilepsy Picture
Figure Meningitis Picture
Figure Others Picture
Table Global Brain Disease Revenue (Million USD) by Application (2013-2023)
Figure Brain Disease Revenue Market Share by Applications in 2017
Figure Hospitals Pharmacy Picture
Figure Online Pharmacy Picture
Figure Pharmacy Picture
Table Global Market Brain Disease Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Brain Disease Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Brain Disease Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Brain Disease Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Brain Disease Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Brain Disease Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Brain Disease Revenue (Million USD) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Brain Disease Type and Applications
Table Pfizer Brain Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Brain Disease Type and Applications
Table Eli Lilly Brain Disease Revenue, Gross Margin and Market Share (2016-2017)
Table F. Hoffmann La Roche Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann La Roche Brain Disease Type and Applications
Table F. Hoffmann La Roche Brain Disease Revenue, Gross Margin and Market Share (2016-2017)
Table GE Healthcare Basic Information, Manufacturing Base and Competitors
Table GE Healthcare Brain Disease Type and Applications
Table GE Healthcare Brain Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Janssen Pharmaceuticals Brain Disease Type and Applications
Table Janssen Pharmaceuticals Brain Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Abbvie Basic Information, Manufacturing Base and Competitors
Table Abbvie Brain Disease Type and Applications
Table Abbvie Brain Disease Revenue, Gross Margin and Market Share (2016-2017)
Table AC Immune Basic Information, Manufacturing Base and Competitors
Table AC Immune Brain Disease Type and Applications
Table AC Immune Brain Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Brain Disease Type and Applications
Table Allergan Brain Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Brain Disease Type and Applications
Table Merck Brain Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Brain Disease Type and Applications
Table Novartis Brain Disease Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Brain Disease Type and Applications
Table AstraZeneca Brain Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Global Brain Disease Revenue (Million USD) by Players (2013-2018)
Table Global Brain Disease Revenue Share by Players (2013-2018)
Figure Global Brain Disease Revenue Share by Players in 2016
Figure Global Brain Disease Revenue Share by Players in 2017
Figure Global Top 5 Players Brain Disease Revenue Market Share in 2017
Figure Global Top 10 Players Brain Disease Revenue Market Share in 2017
Figure Global Brain Disease Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Brain Disease Revenue (Million USD) by Regions (2013-2018)
Table Global Brain Disease Revenue Market Share by Regions (2013-2018)
Figure Global Brain Disease Revenue Market Share by Regions (2013-2018)
Figure Global Brain Disease Revenue Market Share by Regions in 2017
Figure North America Brain Disease Revenue and Growth Rate (2013-2018)
Figure Europe Brain Disease Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Brain Disease Revenue and Growth Rate (2013-2018)
Figure South America Brain Disease Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Brain Disease Revenue and Growth Rate (2013-2018)
Table North America Brain Disease Revenue by Countries (2013-2018)
Table North America Brain Disease Revenue Market Share by Countries (2013-2018)
Figure North America Brain Disease Revenue Market Share by Countries (2013-2018)
Figure North America Brain Disease Revenue Market Share by Countries in 2017
Figure USA Brain Disease Revenue and Growth Rate (2013-2018)
Figure Canada Brain Disease Revenue and Growth Rate (2013-2018)
Figure Mexico Brain Disease Revenue and Growth Rate (2013-2018)
Table Europe Brain Disease Revenue (Million USD) by Countries (2013-2018)
Figure Europe Brain Disease Revenue Market Share by Countries (2013-2018)
Figure Europe Brain Disease Revenue Market Share by Countries in 2017
Figure Germany Brain Disease Revenue and Growth Rate (2013-2018)
Figure UK Brain Disease Revenue and Growth Rate (2013-2018)
Figure France Brain Disease Revenue and Growth Rate (2013-2018)
Figure Russia Brain Disease Revenue and Growth Rate (2013-2018)
Figure Italy Brain Disease Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Brain Disease Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Brain Disease Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Brain Disease Revenue Market Share by Countries in 2017
Figure China Brain Disease Revenue and Growth Rate (2013-2018)
Figure Japan Brain Disease Revenue and Growth Rate (2013-2018)
Figure Korea Brain Disease Revenue and Growth Rate (2013-2018)
Figure India Brain Disease Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Brain Disease Revenue and Growth Rate (2013-2018)
Table South America Brain Disease Revenue by Countries (2013-2018)
Table South America Brain Disease Revenue Market Share by Countries (2013-2018)
Figure South America Brain Disease Revenue Market Share by Countries (2013-2018)
Figure South America Brain Disease Revenue Market Share by Countries in 2017
Figure Brazil Brain Disease Revenue and Growth Rate (2013-2018)
Figure Argentina Brain Disease Revenue and Growth Rate (2013-2018)
Figure Colombia Brain Disease Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Brain Disease Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Brain Disease Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Brain Disease Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Brain Disease Revenue Market Share by Countries in 2017
Figure Saudi Arabia Brain Disease Revenue and Growth Rate (2013-2018)
Figure UAE Brain Disease Revenue and Growth Rate (2013-2018)
Figure Egypt Brain Disease Revenue and Growth Rate (2013-2018)
Figure Nigeria Brain Disease Revenue and Growth Rate (2013-2018)
Figure South Africa Brain Disease Revenue and Growth Rate (2013-2018)
Table Global Brain Disease Revenue (Million USD) by Type (2013-2018)
Table Global Brain Disease Revenue Share by Type (2013-2018)
Figure Global Brain Disease Revenue Share by Type (2013-2018)
Figure Global Brain Disease Revenue Share by Type in 2017
Table Global Brain Disease Revenue Forecast by Type (2018-2023)
Figure Global Brain Disease Market Share Forecast by Type (2018-2023)
Figure Global Brain Cancer Revenue Growth Rate (2013-2018)
Figure Global Alzheimer Disease Revenue Growth Rate (2013-2018)
Figure Global Alcoholism Revenue Growth Rate (2013-2018)
Figure Global Amnesia Revenue Growth Rate (2013-2018)
Figure Global Epilepsy Revenue Growth Rate (2013-2018)
Figure Global Meningitis Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Brain Disease Revenue by Application (2013-2018)
Table Global Brain Disease Revenue Share by Application (2013-2018)
Figure Global Brain Disease Revenue Share by Application (2013-2018)
Figure Global Brain Disease Revenue Share by Application in 2017
Table Global Brain Disease Revenue Forecast by Application (2018-2023)
Figure Global Brain Disease Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Pharmacy Revenue Growth Rate (2013-2018)
Figure Global Online Pharmacy Revenue Growth Rate (2013-2018)
Figure Global Pharmacy Revenue Growth Rate (2013-2018)
Figure Global Brain Disease Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Brain Disease Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Brain Disease Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Brain Disease Revenue Market Forecast (2018-2023)
Figure Europe Brain Disease Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Brain Disease Revenue Market Forecast (2018-2023)
Figure South America Brain Disease Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Brain Disease Revenue Market Forecast (2018-2023)